Abstract
Most drugs initiate their effects by binding to a drug target. The kinetics of binding have the potential to influence the utility of a drug. Physiology uses the magnitude of kinetic barriers to differentiate between reversible and irreversible states, leading to differentiated phenotypes. Under the appropriate circumstances the therapeutic index of some drugs is influenced by the kinetics and reversibility of a system. The ability for differentiated binding kinetics to define irreversible or reversible states and the impact of these differentiated states on a clinical outcome is proposed here to contribute to the magnitude of gastrointestinal toxicity observed with nonsteroidal anti-inflammatory agents (NSAIDs). This example and others highlight the potential for differentiated binding kinetics to provide clinical differentiation.
Keywords: Kinetics, Pharmacology, Cyclooxygenase, NSAID, GI toxicity, Irreversible
Letters in Drug Design & Discovery
Title: Can Binding Kinetics Translate to a Clinically Differentiated Drug? From Theory to Practice
Volume: 3 Issue: 8
Author(s): David C. Swinney
Affiliation:
Keywords: Kinetics, Pharmacology, Cyclooxygenase, NSAID, GI toxicity, Irreversible
Abstract: Most drugs initiate their effects by binding to a drug target. The kinetics of binding have the potential to influence the utility of a drug. Physiology uses the magnitude of kinetic barriers to differentiate between reversible and irreversible states, leading to differentiated phenotypes. Under the appropriate circumstances the therapeutic index of some drugs is influenced by the kinetics and reversibility of a system. The ability for differentiated binding kinetics to define irreversible or reversible states and the impact of these differentiated states on a clinical outcome is proposed here to contribute to the magnitude of gastrointestinal toxicity observed with nonsteroidal anti-inflammatory agents (NSAIDs). This example and others highlight the potential for differentiated binding kinetics to provide clinical differentiation.
Export Options
About this article
Cite this article as:
Swinney C. David, Can Binding Kinetics Translate to a Clinically Differentiated Drug? From Theory to Practice, Letters in Drug Design & Discovery 2006; 3 (8) . https://dx.doi.org/10.2174/157018006778194754
DOI https://dx.doi.org/10.2174/157018006778194754 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Lipid Effects of Statins: Emerging New Indications
Current Vascular Pharmacology Ecto-ADP-Ribosyltransferases (ARTs): Emerging Actors in Cell Communication and Signaling
Current Medicinal Chemistry Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry Elevations in the Levels of NF-κB and Inflammatory Chemotactic Factors in the Brains with Alzheimer’s Disease - One Mechanism May Involve α3 Nicotinic Acetylcholine Receptor
Current Alzheimer Research CD93 and Related Family Members: Their Role in Innate Immunity
Current Drug Targets Ziziphi Spinosae Semen: A Natural Herb Resource for Treating Neurological Disorders
Current Topics in Medicinal Chemistry Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation
Current Stem Cell Research & Therapy Curcumin and its Derivatives: Their Application in Neuropharmacology and Neuroscience in the 21st Century
Current Neuropharmacology RNA Interference as Therapeutics for Hepatocellular Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Function of miRNA in Controlling Drug Resistance of Human Cancers
Current Drug Targets In Vitro Hematopoiesis Reveals a Novel denDritic-Like Cell Present in Murine Spleen
Current Stem Cell Research & Therapy Epigenetic Modification in Macrophages: A Promising Target for Tumor and Inflammation-associated Disease Therapy
Current Topics in Medicinal Chemistry Opioid Free Anaesthesia and Cancer
Current Pharmaceutical Design Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2
Current Medicinal Chemistry Effects of Excitotoxic Lesion with Inhaled Anesthetics on Nervous System Cells of Rodents
Current Pharmaceutical Design Snake Envenomation and Innate Immune System: An Overview
Venoms and Toxins Proanthocyanidins in Health Care: Current and New Trends
Current Medicinal Chemistry Synthetic Approaches of Pyrazolyl Quinolines
Mini-Reviews in Organic Chemistry Discovery, Development and Design of Anthocyanins-Inspired Anticancer Agents: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Superior Anticancer Potential of Nano-Paclitaxel Combined Bevacizumab Treatment in Ovarian Cancer
Current Pharmaceutical Biotechnology